Search by alphabetical order

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back

Ilka Lowensteyn, PhD

Research Institute of the McGill University Health Centre

Regular Member
Cardiovascular Diseases and Critical Care
Endocrinology, Diabetes, Nutrition and Kidney Diseases


McGill University Health Centre (MUHC)

Medical scientist, Division of Clinical Epidemiology


McGill University

Department of Medicine


Research Interest


My research focuses on studying the benefits of exercise for the primary and secondary prevention of cardiovascular disease. I am also evaluating the clinical impact of computerized risk profiles and web-based wellness programs on adherence to treatment for cardiovascular risk factors. Other research interests include evaluating the benefits of exercise for preventing and treating diseases such as cancer, metabolic syndrome, and obesity.

Research Foci


  • cardiac rehabilitation
  • cardiovascular risk assessment
  • web-based wellness
  • exercise training
  • workplace wellness

Keywords


Cardiac rehabilitation, exercise physiology, kinesiology, prevention, wellness

Selected Publications


Click on Pubmed to see my current publications list

  • Lavoie-Tremblay M, Sounan C, Martin K, Trudel J, Lavigne G, Grover S, Lowensteyn I. Determinants and benefits of physical activity maintenance in hospital employees. Health Care Manag J 2014;33:82-90.

  • Banack HR, Holly CD, Lowensteyn I, Masse L, Marchand S, Grover SA, DaCosta D. The association between sleep disturbance, depressive symptoms, and health-related quality of life among cardiac rehabilitation participants. J Cardiopulm Rehabil Prev 2014 Mar 27 (Epub ahead of print).

  • Banack H, Grover S, Kaouache M, Marchand S, Lowensteyn I. Cardiovascular risk screening in community pharmacies: The My Health Check-Up Study. Can Pharmacists J 2012;145:268-275.

  • Wong P, Muanza T, Hijal T, Masse L, Pillay S, Lowensteyn I, Gold M, Grover S. Effect of exercise in reducing breast and chest-wall pain in patients with breast: A pilot study. Curr Oncol. 2012;19:129-35.

  • Grover S, Lowensteyn I. The challenges and benefits of cardiovascular risk assessment in clinical practice. Can J Cardiol 2011;27:481-487.